Nykredit A/S’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Nykredit A/S's LLY Position: Q3 2026 in Review
Nykredit A/S increased its Eli Lilly (LLY) stake by 3.1% in Q3 2026, buying an estimated $12M and bringing the position to 337,792 shares worth $391M. The position accounts for 1.42% of the portfolio, ranked #9.
Nykredit A/S first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $393M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Nykredit A/S held 337,792 shares of Eli Lilly worth $391M as of Q3 2026.
- Nykredit A/S bought 10,204 Eli Lilly shares in Q3 2026, an estimated $12M.
- Eli Lilly made up 1.42% of Nykredit A/S's portfolio in Q3 2026, its #9 holding.
- Nykredit A/S first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
- Nykredit A/S's Eli Lilly position peaked at $393M in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.